EPHA1 and myalgic encephalomeyelitis/chronic fatigue syndrome: The concurring evidence from the analysis of our dataset highlights the ephrin-Eph signaling pathway as a central component disrupted in our 20 ME/CFS patients compared to the 20 healthy controls.